273
Views
51
CrossRef citations to date
0
Altmetric
Research Article

γ-Irradiation Enhances Apoptosis Induced by Cannabidiol, a Non-psychotropic Cannabinoid, in Cultured HL-60 Myeloblastic Leukemia Cells

, , , , &
Pages 1767-1773 | Published online: 01 Jul 2009

References

  • Afford, S. and Randhawa, S. (2000) "Apoptosis", Mol. Pathol. 53, 55–63.
  • Kilche, K.O. and Hoffken, K. (1999) "The role of apoptosis in hematologic malignancies and modulation of apoptosis as a new therapeutic approach", J. Cancer Res. Clin. Oncol. 125, 226–231.
  • Lorenz, H.M., Hermann, M. and Kalden, J.R. (2001) "The pathogenesis of autoimmune diseases", Scand. J. Clin. Lab. Investig. Suppl. 235, 16–25.
  • Gaoni, Y. and Mechoulam, R. (1964) "Isolation, structure and partial synthesis of an active constituent of hashish", J. Am. Chem. Soc. 86, 1646.
  • Mechoulam, R. and Ben-Shabat, S. (1999) "From Gan-Zi-Gun-Nu to anandamide and 2-arachidonoyl-glycerol, the ongoing story of Cannabis", Nat. Prod. Rep. 16, 131–143.
  • Iversen, L.L. (2000) The Science of Marijuana (Oxford University Press, Oxford, UK).
  • Sanchez, C., Galve-Roperh, I., Canova, C., Brachet, P. and Guzman, M. (1998) "Delta-9-tetrahydrocannabinol induces apoptosis in C6 glioma cells", FEBS Lett. 436, 6–10.
  • Zhu, W., Friedamn, H. and Klein, T.W. (1998) "Delta-9- tetrahydrocannabinol induces apoptosis in macrophages and lymphocytes: involvement of Bcl-2 and caspase-1", J. Pharmacol. Exp. Ther. 286, 1103–1109.
  • McKallip, R.J., Lombard, C., Martin, B.R., Nagarkatti, M. and Nagarkatti, P.S. (2002) "Delta-9-tetrahydrocannabinol-induced apoptosis in the thymus and spleen as a mechanism of immunosuppression in vivo", J. Pharmacol. Exp. Ther. 302, 451–465.
  • Campbell, V.A. (2001) "Tetrahydrocannabinol-induced apoptosis of cultured cortical neurones is associated with cytochrome c release and caspase-3 activation", Neuropharmacology 40, 702–709.
  • Devane, W.A., Hanus, L., Breuer, A., Pertwee, R.G., Stevenson, L.A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A. and Mechoulam, R. (1992) "Isolation and structure of a brain constituent that binds to the cannabinoid receptor", Science 258, 1946–1949.
  • Schwarz, H., Blanco, F.J. and Lotz, M. (1994) "Anandamide, an endogenous cannabinoid receptor agonist inhibits lymphocyte proliferation and induces apoptosis", J. Neuroimmunol. 55, 107–115.
  • De-Petrocellis, L., Melck, D., Palmisano, A., Bisogno, T., Laezza, C., Bifulco, M. and Di Marzo, V. (1998) "The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation", Proc. Natl Acad. Sci. USA 95, 8375–8380.
  • Maccarrone, M., Lorenzon, T., Bari, M., Melino, G. and Finazzi- Agro, A. (2000) "Anandamide induces apoptosis in human cells via vanilloid receptors. Evidence for a protective role of cannabinoid receptors", J. Biol. Chem. 275, 31938–31945.
  • Guzman, M., Sanchez, C. and Galve-Roperh, I. (2001) "Control of the cell survival/death decision by cannabinoids", J. Mol. Med. 78, 613–625.
  • Bifulco, M. and Di Marzo, V. (2002) "Targeting the endocannabinoid system in cancer therapy: a call for further research", Nature Med. 8, 547–550.
  • Downer, E., Boland, B., Fogarty, M. and Campbell, V. (2001) "Delta-9-tetrahydrocannabinol induces the apoptotic pathway in cultured cortical neurones via activation of the CB1 receptor", Neuroreport 12, 3973–3978.
  • Sanchez, C., de-Ceballos, M.L., del-Pulgar, T.G., Rueda, D., Corbacho, C., Velasco, G., Galve-Roperh, I., Huffman, J.W., Ramon, Y., Cajal, S. and Guzman, M. (2001) "Inhibition of glioma growth in vivo by selective activation of the CB(2) cannabinoid receptor", Cancer Res. 61, 5784–5789.
  • McKallip, R.J., Lombard, C., Fisher, M., Martin, B.R., Rye, S., Grant, S., Nagarkatti, P.S. and Nagarkatti, M. (2002b) "Targetting CB2 cannabinoid receptors as a novel therapy to t malignant lymphoblastic disease", Blood 100, 627–634.
  • Ruiz, L., Miguel, A. and Diaz-Laviada, I. (1999) "D9-Tetrahydrocannabinol induces apoptosis in human prostate PC-3 cells via a receptor-independent mechanism", FEBS Lett. 458, 400–404.
  • Gomez-del-Pulgar, T., Velasco, G., Sanchez, C., Haro, A. and Guzman, M. (2002) "De novo-synthesized ceramide is involved in cannabinoid-induced apoptosis", Biochem. J. 363, 183–188.
  • Sarker, K.P., Obara, S., Nakata, M., Kitajima, I. and Maruyama, I. (2000) "Anandamide induces apoptosis of PC-12 cells: involvement of superoxide and caspase-3", FEBS Lett. 472, 39–44.
  • Mechoulam, R., Parker, L.A. and Gallily, R. (2002) "Cannabidiol: an overview of some chemical and pharmacological aspects. Part II: Pharmacological aspects", J. Clin. Pharmacol. 42, 11S–19S.
  • Malfait, A.M., Gallily, R., Sumariwalla, P.F., Malik, A.S., Andreakos, E., Mechoulam, R. and Feldmann, M. (2000) "The non-psychoactive cannabis-constituent cannabidiol is an oral antiarthritic therapeutic in murine collagen-induced arthritis", Proc. Natl Acad. Sci. USA 97, 9561–9566.
  • Perlman, H., Pagliari, L.J. and Volin, M.V. (2001) "Regulation of apoptosis and cell cycle activity in rheumatoid arthritis", Curr. Mol. Med. 1, 597–608.
  • Baek, S.H., Srebnik, M. and Mechoulam, R. (1985) "Borontrifluoride on alumina�a modified Lewis acid reagent. An improved synthesis of cannabidiol", Tetrahedron Lett. 26, 1083–1086.
  • Nagy, E., Szakonyi, P. and Gergely, P. (1998) "Imuthiol inhibits the etopobide�induced apoptosis in HL-60 cells", Immunol. Lett. 64, 1–4.
  • Appel, S.H., Wellhausen, S.R., Montgomery, R., DeWeese, R.C. and Polk, H.C. Jr (1989) "Experimental and clinical significance of endotoxin-dependent HLA-DR expression on monocytes", J. Surg. Res. 47, 39–44.
  • Latt, S.A. and Stetten, G. (1976) "Special studies on 33258 Hoecst and related bisbenzimidazole dyes useful for fluorescent detection of deoxyribonucliec acid synthesis", J. Histochem. Cytochem. 24, 24–33.
  • Allen, S., Sotos, J., Sylte, M.J. and Czuprynski, C.J. (2001) "Use of Hoechst 33342 staining to detect apoptotic changes in bovine mononuclear phagocytes infected with Mycobacterium avium subsp. paratuberculosis", Clin. Diagn.-Lab. Immunol. 8, 460–464.
  • Zhuang, S.M., Landegent, J.E., Verschueren, C.A., Falkenburg, J.H., van-Ormondt, H., van-der-Eb, A.J. and Noteborn, H.M. (1995) "Apoptin, a protein encoded by chicken anemia virus, induces cell death in various human hematologic malignant cells in vitro", Leukemia 9\(Suppl. 1), S118–S120.
  • Bishop, R.P. and Young, I.T. (1977) "The automated classification of mitotic phase for human chromosome spreads", J. Histochem. Cytochem. 7, 730–740.
  • Bisogno, T., Hanus, L., De Petrocellis, L., Tchilibon, S., Ponde, D.E., Brandi, I., Moriello, A.S., Davis, J.B., Mechoulam, R. and Di Marzo, V. (2001) "Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide", Br. J. Pharmacol. 134, 845–852.
  • Razdan, R.K. (1986) "Structure-activity relationships in cannabinoids", Pharmacol. Rev. 38, 75–149.
  • Leite, J.R., Carlini, E.A., Lander, N. and Mechoulam, R. (1982) "Anticonvulsant effects of the (2) and (�) isomers of cannabidiol and their dimethylheptyl homologs", Pharmacology 24, 141–146.
  • Munson, A.E., Harris, L.S., Friedman, M.A., Dewey, W.L. and Carchman, R.A. (1975) "Antimeoplastic activity of cannabinoids", J. Natl Cancer Inst. 55, 597–602.
  • Carchman, R.A., Harris, L.S. and Munson, A.E. (1976) "The inhibition of DNA syntheses by cannabinoids", Cancer Res. 36, 95–100.
  • Melck, D., De Petrocellis, L., Orlando, P., Bisogno, T., Laezza, C., Bifulco, M. and Di Marzo, V. (2000) "Suppression of nerve growth factor Tnk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferation", Endocrinology 141, 118–126.
  • Galve-Roperh, I., Sanchez, C., Cortes, M.L., del Pulgar, G.T., Izquierdo, M. and Guzman, M. (2000) "Anti-tumor action of cannabinoids: involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation", Nature Med. 6, 313–319.
  • Frankel, A.E., Schuster, M.W. and Jurcic, J.G. (2001) "Novel therapeutics for chemotherapy-resistant acute myeloid leukaemia", BioDrugs 15, 55–71.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.